When generics go wrong

When generics go wrong

Earlier this year The New York Times highlighted an unexpected but serious risk for the American consumer when a doctor or chemist prescribes or dispenses generic equivalent drugs, rather than the original patented brand. Who does one sue?

This is potentially of concern to South Africans, as generic equivalent medicines are widely used here, where approval and licensing procedures closely follow American precedents. The issue is graphically demonstrated by two case studies quoted in The New York Times

Like to see more ?

Subscribe to our on-line edition !

For a mere R305.00 per year you get the convenience of our online version including:
  • Twelve monthly issues of Noseweek delivered to your browser
  • A searchable archive
  • Access to every back issue since 1993 !
  • A downloadable PDF version

If it’s just the article you are after, you can purchase it by clicking here.

Tempted ?

For a taste of what awaits you, you are welcome to browse this free issue.

Share this article:

Reader's comments

Like to add your own comment ? Please click here to subscribe - OR -
Submitted by : Frederick Truter on 2012-08-30 08:51:29
I do not think you have to dig deep to publish the exact same article with the heading “When original patented brands go wrong”. In my opinion this article is totally biased and is not informing us as readers of how generic drugs or original patented drugs contribute to the well being of society. There is no perfection!


While every reasonable effort is taken to ensure the accuracy and soundness of the contents of this publication, neither the authors nor the publishers of this website bear any responsibility for the consequences of any actions based on the information contained therein.

Important information regarding cookies
By using this website, you consent to the use of cookies in accordance with our Privacy Policy.